News
-
Dispensary Corner
Thursday | Dec 6 2018
06 Dec 18ONCE upon a time the bad kids at school would be busted for smoking cigarettes in the toilet block, but how things have changed; now they're getting in trouble for vaping.
-
Travel Specials 06 Dec 18
Thursday | Dec 6 2018WELCOME to Pharmacy Daily’s travel feature where each week we highlight a couple of great travel.
-
AZ direct supply backdown
Wednesday | Dec 5 2018ASTRAZENECA (AZ) has announced a transition away from its current exclusive direct supply arrangements for 14 high-cost medicines (PD 31 Oct 2017), with the full range of products to become available both through current provider DHL and the key pharmaceutical wholesalers from 01 Feb 2019 (PD breaking news yesterday).
-
Chisholm Chemist is Capital Champ
Wednesday | Dec 5 2018CANBERRA'S Capital Chemist Chisholm has been named the top Pharmacy of the Year for the Capital Chemist group.
-
Special Access Scheme online system
Wednesday | Dec 5 2018THE Therapeutic Goods Administration has released details of its new online system to enable the electronic submission of Special Access Scheme (SAS) applications and notifications to the TGA.
-
PBS forms online
Wednesday | Dec 5 2018THE Department of Human Services has made new forms available online for pharmacists and customers to download.
-
ASMI AGM last week
Wednesday | Dec 5 2018THE Australian Self Medication Industry (ASMI) has elected Theresa Agnew, GSK Consumer Healthcare Area General Manager Australia and NZ to its Board of Directors.
-
A rose by any other…
Wednesday | Dec 5 2018"A ROSE by any other name would smell as sweet", said William Shakespeare's Juliet, but a drug name pronounced differently may not, according to an editorial in this month's edition of Australian Prescriber, the official organ of NPS MedicineWise.
-
Omega-3 health
Wednesday | Dec 5 2018THE secret to healthy ageing may, in part, be linked to consuming an extra serving of fish each week, new research published in the British Medical Journal has reported this week.
-
Fasenra onto PBS
Wednesday | Dec 5 2018ASTRAZENECA has announced the Pharmaceutical Benefits Scheme listing of its Fasenra (benralizumab) for patients with severe eosiniphilic asthma who meet specific criteria.
